To determine whether CCR9 is involved in the recruitment of CD4+ and CD8+ effector T cells during CRC development, we analyzed the cLP infiltrate under basal (CTRL), inflammatory (DSS) and cancer promoting conditions (AOM/DSS), using flow cytometry (Fig 3A). Here, CCR9 is linked to cancer.